Effect of Helicobacter pylori Infection on Duodenitis in Patients with Dyspepsia/Dispepsisi Olan Hastalarda Helicobacter pylori Enfeksiyonunun Duodenit Uzerine Etkisi.
Dyspepsia is recurrent and chronic upper abdominal pain or discomfort. It affects up to 40% of the general population and is a significant cause of reduced quality of life among patients (1). Dyspeptic symptoms have been clustered into three categories as follows: ulcer-like dyspepsia in which the predominant symptom is discomfort and pain located in the upper abdomen (most troublesome); dysmotility-like dyspepsia, a bothersome or unpleasant discomfort originating in the upper abdomen associated with upper abdominal fullness, bloating, nausea, or early satiety; and nonspecific/unspecified dyspepsia characterized as the presence of symptoms that do not meet the criteria for dysmotility-like or ulcer-like dyspepsia (2). Recent studies have shown that duodenal mucosal permeability increases in patients with functional dyspepsia (3, 4). Therefore, impaired duodenal mucosal barrier function might contribute to the pathophysiology of dyspepsia.
The presence of Helicobacter pylori (H. pylori) is one of the leading causes of peptic ulcer, duodenal ulcer, duodenitis, and chronic gastritis. Additionally, H. pylori may be associated with various extra-gastrointestinal diseases, such as idiopathic thrombocytopenic purpura, coronary artery disease, unexplained iron deficiency anemia, and ischemic stroke (5). H. pylori is a small gram-negative bacillus that inhabits the human stomach and duodenum (6). Its role in producing dyspepsia symptoms is not completely understood. However, duodenitis is often associated with the presence of H. pylori (7, 8).
A recent systematic meta-analysis and review has demonstrated that although H. pylori prevalence widely varies between regions and countries, more than half the world's population is infected (9). In Turkey, H. pylori prevalence has been reported to be very high, estimated as 82.5% in the adult population (10). The goal of this study was to assess the presence of an association between H. pylori positivity and endoscopic or histological features of the duodenal mucosa in patients referred for endoscopy to investigate dyspepsia.
The present study group consisted of 131 adult patients with dyspepsia evaluated at a tertiary medical center. The criteria for inclusion were subjects aged >18 years who underwent endoscopy for dyspepsia. The exclusion criteria were as follows: an evidence of gastroduodenal malignancies, duodenal ulcer, gastric ulcer, or scar on gastroscopy; liver, biliary, or pancreatic diseases on ultrasound examination; the use of corticosteroids, immunosuppressives, proton pump inhibitors, oral anticoagulants, aspirin, antibiotics known to be active against H. pylori, or other non-steroidal anti-inflammatory drugs within the preceding 4 weeks; presence of Crohn's disease or Zollinger-Ellison syndrome involving the duodenum; pregnancy; previous upper gastrointestinal surgery; renal or hepatic failure; or other severe concomitant illnesses. Routine clinical and biochemical evaluations were performed on all subjects. Dyspepsia diagnosis was according to the Rome III criteria. The control group included patients with H. pylori-negative dyspepsia. The study protocol was reviewed and approved by the local Ethics Committee, and the study was conducted in accordance with the guidelines in the Declaration of Helsinki. Written informed consent was obtained from all patients and volunteers.
Endoscopy and Biopsy Sampling
All patients underwent the routine preparation for endoscopy as follows: fasting for 8 h for liquids and solids. Patients were submitted to 5-10 puffs of 10% lidocaine spray in the oropharynx just before the endoscopy. Endoscopy was performed under intravenous midazolam (0.07-0.1 mg/kg) sedation. A flexible gastroscope (Fujinon EG-250WR5, Saitama, Japan) was used. Sydney classification was employed for endoscopic findings of duodenal morphology, and the severity of endoscopic duodenitis was described as mild, moderate, or severe (11). One gastric antral, one gastric corpus, and four duodenal biopsies were taken from the duodenal bulb during each endoscopic examination. Biopsies were taken through endoscopic biopsy forceps from the mucosa of the duodenal bulb of the patients. Among these biopsies, one antral, one corpus, and one duodenal specimen were used to detect H. pylori by the rapid urease test, and the others were used for histological examination.
Biopsies were fixed in 10% formalin, embedded in paraffin, and cut in sequential 3-[micro]m sections. For histological examination, sections of the tissue samples were stained with hematoxylin and eosin. Sections were stained with Alcian blue periodic acid-Schiff (AB/PAS) for assessing and identifying the extent of duodenal gastric metaplasia. Sections were also immunostained for CD3 to assess the number of intraepithelial lymphocytes present in each specimen. Histological material was examined by an experienced pathologist who was blinded to clinical and endoscopic tests. Duodenal biopsy specimens were graded according to the updated Sydney System (12). The histological severity of chronic inflammation in mucosa was assessed on a scale of four grades (normal, mild, moderate, and severe) according to the degree of mononuclear cell infiltration. Acute inflammation was characterized as the degree of stromal and epithelial neutrophil infiltration and was also graded as follows: 0, none; 1, mild; 2, moderate; 3, severe.
Data were presented as percentage or mean[+ or -]standard deviation. The SPSS (Statistical Package for Sociel Sciences) Version 22.0 (IBM Corp.; Armonk, NY, USA) was used for statistical analysis. Unpaired Student's t-test was used for comparisons of the differences between mean values of two groups. The Mann-Whitney U-test was used to detect significant differences between histopathological scores. Chi-squared test was used to analyze frequencies. P-values presented are two-tailed, with a significant level of 0.05.
The age of the patients ranged from 18-85 (mean of 46.0[+ or -]16.0) years. Among all the patients, 77 (58.8%) were females and 54 (41.2%) were males. The overall H. pylori infection prevalence was 54.2% (n=71/131). In total, 87 patients (66.4%) presented with ulcer-like dyspepsia, whereas 44 patients (33.6%) presented with dysmotility-like dyspepsia. In total, 7 (5.3%) patients presented with celiac disease, and 4 (3.1%) presented with duodenal gastric metaplasia.
There were no differences in blood biochemical parameters of the patients with and without H. pylori in terms of hemoglobin, hematocrit, mean corpuscular volume, F[e.sup.2+], transferrin saturation, total iron binding capacity, vitamin [B.sub.12], and folic acid levels (Table 1). However, a marked decrease in ferritin levels was noted in the H. pylori-positive group (p=0.001).
Based on endoscopic duodenitis classification, there was a high frequency of erosive duodenitis but a low incidence of nodular duodenitis in the H. pylori-positive group compared with that in the H. pylori-negative group (p=0.039, Figure 1). Based on endoscopic duodenitis classification, there were no significant changes in the distribution of patients with ulcer-like dyspepsia or patients with dysmotility-like dyspepsia (p=0.125, Figure 2). No marked changes were noted in the severity of duodenitis in the H. pylori-negative and H. pylori-positive groups (p=0.308, Figure 3). Histopathological analysis revealed that there were marked augmentations in both duodenal intraepithelial lymphocytosis and villus obliterations in the H. pylori-positive group (p<0.001 for both, Figure 4).
In this study, we showed that the frequency of erosive duodenitis was high in H. pylori-positive patients. Moreover, augmented duodenal intraepithelial lymphocytosis, villous obliterations, and diminished ferritin levels were detected in H. pylori-positive patients. Our results suggest that there is an association between H. pylori infection and duodenitis in patients with dyspepsia. The contribution of the presence of H. pylori to duodenitis has been previously described in patients with duodenal ulcer (13). This previous study has indicated that biopsies with regenerative changes demonstrated a significant polymorphonuclear leukocyte infiltration regardless of the duodenal H. pylori status. In biopsies with no regenerative changes, H. pylori colonization was commonly associated with leukocyte infiltration (13). Other studies have also observed that histological duodenitis is often associated with H. pylori (75%-82%) (7, 14). These findings imply that H. pylori is another critical factor in the development of lymphocyte and leukocyte infiltration in the duodenal mucosa.
We observed an increased erosive duodenitis in H. pylori-positive patients. Few studies have investigated the possible role of and the association between H. pylori infection and the appearance of duodenitis. It has been postulated that the presence of endoscopic findings of duodenitis may appear from H. pylori infection or from an acid-pepsin attack and is generally associated with histopathologic abnormalities, including gastric metaplasia (15). H. pylori increases the production of ammonia in the gastric lumen by its urease activity. Ammonia toxicity may cause cell destruction and the disintegration of cell permeability and active transport (6). Moreover, H. pylori produces factors capable of chemoattracting and activating monocytes and neutrophils that induce inflammation (16). The epithelium responds to H. pylori infection by mucin depletion, cellular exfoliation, the desquamation of the epithelium, and compensatory regenerative changes (17, 18). H. pylori is associated with cytotoxicity on mucosal cells when spread to the duodenal mucosa. H. pylori-induced inflammatory injury may stimulate the development of further duodenal gastric metaplasia (13, 17). In contrast, it has been demonstrated that there is an insignificant difference in the severity of endoscopic duodenitis between H. pylori-negative and -positive patients (19). Furthermore, effective H. pylori eradication has been reported to produce no marked change in endoscopic appearance (19).
Diffuse nodular duodenitis is a distinctive type of chronic duodenitis. Currently, little is known regarding the mechanism of its pathogenesis. Our data showed that there was a decrease in nodular duodenitis in H. pylori-positive patients. Reasons underlying this reduction are not known. Li et al. (20) have shown that neither the acid suppression treatment nor H. pylori eradication can significantly change the appearance of endoscopic nodular duodenitis. Therefore, the presence of H. pylori infection may not be associated with nodular duodenitis.
In the present study, there were increases in villus obliterations in the H. pylori-positive group. These data support the previous observations that reduction in villus size, increased cellular infiltrate, and mucosal architecture abnormalities are noted in biopsies from visually inflamed areas of nonspecific duodenitis (21, 22). Collectively, these findings may suggest that impaired duodenal mucosal barrier function can contribute to the pathophysiology of duodenitis and dyspepsia.
We observed that H. pylori infection is accompanied with diminished serum ferritin levels. Although there is significant heterogeneity among the studies, a recent meta-analysis has demonstrated that serum ferritin levels increased as a consequence of H. pylori eradication treatment (23).
The findings of this study provided updated information and indicated that the presence of gastric H. pylori infection is one of the components that can contribute to the endoscopic, histopathological, and laboratory features of duodenitis. Therefore, the determination of the degree of morphological changes associated with H. pylori infection in dyspepsia is valuable in the treatment and follow-up of patients. Further investigations of effects of H. pylori infection on duodenitis in large prospective studies would be helpful in understanding the pathogenesis of duodenitis.
Ethics Committee Approval: Ethics committee approval was received for this study from the ethics committee of Kocaeli University School of Medicine.
Informed Consent: Written informed consent was obtained from patients who participated in this study.
Peer-review: Externally peer-reviewed.
Author contributions: Concept - B.T.K., O.S. , S.D., Y.G.; Design - B.T.K. , S.D., Y.G., O.S.; Supervision - B.T.K., S.D., O.S.; Resource - B.T.K., S.D., O.S., A.E.Y., R.E.E., S.B., A.B.; Materials - B.T.K., Y.G.; Data Collection and/or Processing - B.T.K, O.S., S.D., Y.G., A.E.Y, R.E.E., S.B., A.B.; Analysis and/or Interpretation - B.T.K., S.D., Y.G., O.S.; Literature Search - B.T.K., S.D.; Writing - B.T.K., S.D.; Critical Reviews - S.D.
Financial Disclosure: The authors declared that this study has received no financial support.
Etik Komite Onayi: Bu calisma icin etik komite onayi Kocaeli Universitesi Tip Fakultesi Etik Kurulu'ndan alinmistir.
Hasta Onami: Yazili hasta onami bu calismaya katilan hastalardan alinmistir.
Hakem Degerlendirmesi: Dis Bagimsiz.
Yazar Katkilari: Fikir - B.T.K., O.S., S.D., Y.G.; Tasarim - B.T.K., S.D., Y.G., O.S.; Denetleme - B.T.K., S.D., O.S.; Kaynaklar - B.T.K., S.D., O.S., A.E.Y, R.E.E., S.B., A.B.; Malzemeler - B.TK., YG.; Veri Toplanmasi ve/veya Islemesi - B.T.K, O.S., S.D., Y.G., A.E.Y, R.E.E., S.B., A.B.; Analiz ve/veya Yorum - B.T.K., S.D., Y.G., O.S.; Literatur Taramasi - B.T.K., S.D.; Yaziyi Yazan - B.T.K., S.D.; Elestirel Inceleme - S.D.
Cikar Catismasi: Yazarlar cikar catismasi bildirmemislerdir.
Finansal Destek: Yazarlar bu calisma icin finansal destek almadiklarini beyan etmislerdir.
(1.) Ford AC, Moayyedi P. Dyspepsia. Curr Opin Gastroenterol 2013; 29: 662-8.
(2.) Dore MP, Pes GM, Bassotti G, Usai-Satta P. Dyspepsia: when and how to test for Helicobacter pylori infection. Gastroenterol Res Pract 2016; 2016: 8463614.
(3.) Vanheel H, Vicario M, Vanuytsel T, Van Oudenhove L, Martinez C, Keita AV, et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut 2014; 63: 262-71.
(4.) Ishigami H, Matsumura T, Kasamatsu S, Hamanaka S, Taida T, Okimoto K, et al. Endoscopy-guided evaluation of duodenal mucosal permeability in functional dyspepsia. Clin Transl Gastroenterol 2017; 8: e83.
(5.) Tan HJ, Goh KL Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review. J Dig Dis 2012; 13: 342-9.
(6.) Kamboj AK, Cotter TG, Oxentenko AS. Helicobacter pylori: the past, present, and future in management. Mayo Clin Proc 2017; 92: 599-604.
(7.) Mirbagheri SA, Khajavirad N, Rakhshani N, Ostovaneh MR, Hoseini SM, Hoseini V. Impact of Helicobacter pylori infection and microscopic duodenal histopathological changes on clinical symptoms of patients with functional dyspepsia. Dig Dis Sci 2012; 57: 967-72.
(8.) Mirbagheri SS, Mirbagheri SA, Nabavizadeh B, Entezari P, Ostovaneh MR, Hosseini SM, et al. Impact of microscopic duodenitis on symptomatic response to Helicobacter pylori eradication in functional dyspepsia. Dig Dis Sci 2015; 60: 163-7.
(9.) Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 2017; 153: 420-9.
(10.) Ozaydin N, Turkyilmaz SA, Cali S. Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with the [.sup.13]C-Urea breath test. BMC Public Health 2013; 13: 1215.
(11.) Tytgat GN. The Sydney System: endoscopic division. Endoscopic appearances in gastritis/duodenitis. J Gastroenterol Hepatol 1991; 6: 223-34.
(12.) Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991; 6: 209-22.
(13.) Satoh K, Kimura K, Yoshida Y, Kasano T, Kihira K, Taniguchi Y Relationship between Helicobacter pylori colonization and acute inflammation of the duodenal mucosa. Am J Gastroenterol 1993; 88: 360-3.
(14.) Caselli M, Gaudio M, Chiamenti CM, Trevisani L, Sartori S, Saragoni L, et al. Histologic findings and Helicobacter pylori in duodenal biopsies. J Clin Gastroenterol 1998; 26: 74-80.
(15.) Wyatt JI, Rathbone BJ, Sobala GM, Shallcross T, Heatley RV, Axon AT, et al. Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol 1990; 43: 981-6.
(16.) Craig PM, Territo MC, Karnes WE, Walsh JH. Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut 1992; 33: 1020-3.
(17.) El-Zimaity HM. Gastric atrophy, diagnosing and staging. World J Gastroenterol 2006; 12: 5757-62.
(18.) Megraud F, Floch P, Labenz J, Lehours P. Diagnostic of Helicobacter pylori infection. Helicobacter 2016; 21 Suppl 1: 8-13.
(19.) Urakami Y, Sano T. Endoscopic duodenitis, gastric metaplasia and Helicobacter pylori. J Gastroenterol Hepatol 2001; 16: 513-8.
(20.) Li XB, Ge ZZ, Chen XY, Liu WZ. Duodenal gastric metaplasia and Helicobacter pylori infection in patients with diffuse nodular duodenitis. Braz J Med Biol Res 2007; 40: 897-902.
(21.) Hasan M, Ferguson A. Measurements of intestinal villi non-specific and ulcer-associated duodenitis-correlation between area of micro-dissected villus and villus epithelial cell count. J Clin Pathol 1981; 34: 1181-6.
(22.) Hasan M, Sircus W, Ferguson A. Duodenal mucosal architecture in non-specific and ulcer-associated duodenitis. Gut 1981; 22: 637-41.
(23.) Hudak L, Jaraisy A, Haj S, Muhsen K. An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia. Helicobacter 2017; 22: e12330.
How to cite:
Konduk BT, Demiryurek S, Yildirim AE, Barutcu S, Er RE, Balkan A, et al. Efect of Helicobacter pylori infection on duodenitis in patients with dyspepsia. Eur J Ther 2018; 24: 12-6.
Bugra Tolga Konduk (1)[iD], Seniz Demiryurek (2)[iD], Abdullah Emre Yldirim (1)[iD], Sezgin Barutcu (1)[iD], Ramazan Erdem Er (1)[iD], Ayhan Balkan (1)[iD], Yesim Gurbuz (3)[iD], Omer Senturk (4)[iD]
(1) Department of Gastroenterology, Gaziantep University School of Medicine, Gaziantep, Turkey
(2) Department of Physiology, Gaziantep University School of Medicine, Gaziantep, Turkey
(3) Department of Pathology, Kocaeli University School of Medicine, Kocaeli, Turkey
(4) Department of Gastroenterology, Kocaeli University School of Medicine, Kocaeli, Turkey
ORCID IDs of the authors: B.T.K. 0000-0002-9138-9984; S.D. 0000-0003-4762-4745; A.E.Y. 0000-0002-4386-9297; S.B. 0000-0003-0823-3215; R.E.E. 0000-0002-9708-1163; A.B. 0000-0002-6475-9847; Y.G. 0000-0002-4278-8241; O.S. 0000-0003-2342-9136.
Corresponding Author/Sorumlu Yazar: Bugra Tolga Konduk E-mail/E-posta: email@example.com
Received/Gelis Tarihi: 30.11.2017 * Accepted/Kabul Tarihi: 14.12.2017
Tablo 1. Characteristics of blood biochemical values of the patients with and without H. pylori Patients without Patients with H. pylori H. pylori Parameters (n=60) (n=71) p Hemoglobin (g/dL) 13.3[+ or -]2.0 13.1[+ or -]2.1 0.580 Hematocrit (%) 38.9[+ or -]5.3 38.7[+ or -]5.5 0.833 MCV (fL) 83.2[+ or -]8.6 82.2[+ or -]12.6 0.605 Fe2+ (mg/dL) 57.5[+ or -]33.1 56.9[+ or -]35.7 0.921 Total iron binding capacity (mg/dL) 302.3[+ or -]52.9 304.3[+ or -]47.8 0.821 Transferrin saturation(%) 18.2[+ or -]8.9 18.1[+ or -]10.1 0.953 Ferritin (mg/dL) 84.5[+ or -]12.3 76.9[+ or -]13.6 0.001 Vitamin B12 (ng/dL) 305.7[+ or -]37.6 292.2[+ or -]41.8 0.056 Folic acid (ng/mL) 9.2[+ or -]5.3 8.8[+ or -]6.0 0.689 MCV: mean corpuscular volume
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Original Research / Ozgun Arastirma|
|Author:||Konduk, Bugra Tolga; Demiryurek, Seniz; Yldirim, Abdullah Emre; Barutcu, Sezgin; Er, Ramazan Erdem;|
|Publication:||European Journal of Therapeutics|
|Date:||Mar 1, 2018|
|Previous Article:||Saglikli Erkeklerde Kinezyolojik Bantlama Uygulamasinin Vucut Kitle Indeksi ile Iliskisinin Degerlendirilmesi/Evaluation the Relationship between...|
|Next Article:||The Efficacy of Haematologic Parameters in the Diagnosis of Missed Abortus/Hematolojik Parametrelerin Missed Abortus Tanisina Etkileri.|